BRAF对合并桥本甲状腺炎的甲状腺乳头状癌淋巴结转移的影响及交互作用
该回顾性研究纳入在华西医院手术的994例合并桥本甲状腺炎的甲状腺乳头状癌患者,分析BRAF突变与淋巴结转移的关系及交互作用。总体淋巴结转移率为52.71%(524/994),BRAF突变率为26.9%(268/994)。BRAF是淋巴结转移的危险因素,并与BMI、高血压、最大径和钙化存在统计学显著交互作用。
要点
- 合并桥本甲状腺炎的甲状腺乳头状癌患者总体淋巴结转移率为52.71%(524/994)。
- BRAF突变率为26.9%(268/994),淋巴结转移患者突变率31.7%高于无转移患者21.5%(P < .001)。
- BRAF与BMI、高血压、最大径、钙化存在统计学显著交互作用(P < .05)。
核心结论
- BRAF是合并桥本甲状腺炎的甲状腺乳头状癌患者淋巴结转移的危险因素。
- BRAF可与BMI、高血压、最大径和钙化发生交互作用,共同影响淋巴结转移。
研究设计与样本
- 回顾性收集在华西医院接受手术的994例合并桥本甲状腺炎的甲状腺乳头状癌患者数据。
- 分析术前特征与淋巴结转移的相关性,并按BRAFV600E突变状态分层。
- 采用逻辑回归分析淋巴结转移的危险因素,并进行交互作用分析。
主要发现
- 总体淋巴结转移率为52.71%(524/994),总体BRAF突变率为26.9%(268/994)。
- 淋巴结转移患者BRAF突变率为31.7%,无淋巴结转移患者为21.5%(P < .001)。
- 全部994例患者中,年龄、BMI、高血压、肿瘤最大径、BRAF突变、肿瘤位置、纵横比、钙化、甲状腺外侵犯是淋巴结转移的危险因素(P < .05)。
- BRAF突变患者中,吸烟、高血压、最大径、钙化、多灶性是淋巴结转移的危险因素(P < .05)。
- BRAF野生型患者中,年龄、BMI、最大径、肿瘤位置、纵横比、肿瘤形状、钙化、甲状腺外侵犯是危险因素(P < .05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The role of B-Raf proto-oncogene (BRAF) in papillary thyroid carcinoma (PTC) with Hashimoto thyroiditis (HT) is unknown. OBJECTIVE: We aimed to explore risk factors affecting lymph node (LN) metastasis and interaction effect of BRAF in PTC patients with HT. METHODS: We retrospectively collected the data of 994 PTC patients with HT who underwent surgery at the West China Hospital. We analyzed the correlations between preoperative characteristics and LN metastasis in overall, and different BRAFV600E-mutation patients. Logistic regression was applied to analyze the risk factors for LN metastasis. Finally, we performed an interaction effect analysis to identify the interaction effect of BRAF. RESULTS: The overall LN metastasis rate was 52.71% (524/994); the overall BRAF mutation rate was 26.9% (268/994). BRAF mutation rates were significantly different in LN metastasis and nonmetastasis patients (31.7% vs 21.5%; P < .001). In all 994 patients, age, body mass index (BMI), hypertension, tumor maximum diameter, BRAF mutation, tumor location, aspect ratio, calcification, and extrathyroidal invasion were risk factors for LN metastasis (P < .05). In BRAF-mutant patients, smoking, hypertension, maximum diameter, calcification, and multifocality were risk factors for LN metastasis (P < .05). In BRAF wild-type patients, age, BMI, maximum diameter, tumor location, aspect ratio, tumor shape, calcification, and extrathyroidal invasion were risk factors (P < .05). Additionally, we found statistically significant interactions between BRAF and BMI, hypertension, maximum diameter, and calcification (P < .05), suggesting the potential interaction effect of BRAF. CONCLUSION: BRAF is a risk factor for LN metastasis in PTC with HT. Meanwhile, BRAF can interact with age, BMI, hypertension, and calcification, which together influence LN metastasis.
引用
- Li P, Liu Y, Wei T, et al. Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis. J Clin Endocrinol Metab. 2024. PMID: 37967234. doi:10.1210/clinem/dgad667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。